Cargando…
Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
BACKGROUND: An accurate and simple risk prediction model that would facilitate earlier detection of pancreatic adenocarcinoma (PDAC) is not available at present. In this study, we compare different algorithms of risk prediction in order to select the best one for constructing a biomarker-based risk...
Autores principales: | Blyuss, Oleg, Zaikin, Alexey, Cherepanova, Valeriia, Munblit, Daniel, Kiseleva, Elena M., Prytomanova, Olga M., Duffy, Stephen W., Crnogorac-Jurcevic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054390/ https://www.ncbi.nlm.nih.gov/pubmed/31857725 http://dx.doi.org/10.1038/s41416-019-0694-0 |
Ejemplares similares
-
Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020) -
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
por: Debernardi, Silvana, et al.
Publicado: (2020) -
Comment on: ‘Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients’
por: De Marco, Margot, et al.
Publicado: (2020) -
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
por: Debernardi, Silvana, et al.
Publicado: (2022) -
Effect of Noise in Intelligent Cellular Decision Making
por: Bates, Russell, et al.
Publicado: (2015)